United States - English - NLM (National Library of Medicine)

hospira, inc. - imipenem (unii: 71otz9ze0a) (imipenem anhydrous - unii:q20im7he75), cilastatin sodium (unii: 5428wxz74m) (cilastatin - unii:141a6amn38) - imipenem anhydrous 250 mg in 100 ml - imipenem and cilastatin for injection (i.v.) for intravenous use is indicated for the treatment of lower respiratory tract infections caused by susceptible strains of staphylococcus aureus (penicillinase-producing isolates), acinetobacter species, enterobacter species, escherichia coli , haemophilus influenzae , haemophilus parainfluenzae , klebsiella species, serratia marcescens. imipenem and cilastatin for injection (i.v.) is indicated for the treatment of urinary tract infections (complicated and uncomplicated) caused by susceptible strains of enterococcus faecalis , staphylococcus aureus (penicillinase-producing isolates), enterobacter species, escherichia coli , klebsiella species, morganella morganii , proteus vulgaris , providencia rettgeri , pseudomonas aeruginosa. imipenem and cilastatin for injection (i.v.) is indicated for the treatment of intra-abdominal infections caused by susceptible strains of enterococcus faecalis , staphylococcus aureus (penicillinase-producing isolates), staphylococ

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - imipenem (unii: 71otz9ze0a) (imipenem anhydrous - unii:q20im7he75), cilastatin sodium (unii: 5428wxz74m) (cilastatin - unii:141a6amn38) - imipenem anhydrous 250 mg in 20 ml - imipenem and cilastatin for injection, usp (i.v.) for intravenous use is indicated for the treatment of lower respiratory tract infections caused by susceptible strains of staphylococcus aureus (penicillinase-producing isolates), acinetobacter species, enterobacter species, escherichia coli , haemophilus influenzae , haemophilus parainfluenzae , klebsiella species, serratia marcescens . imipenem and cilastatin for injection, usp (i.v.) is indicated for the treatment of urinary tract infections (complicated and uncomplicated) caused by susceptible strains of enterococcus faecalis , staphylococcus aureus (penicillinase-producing isolates), enterobacter species, escherichia coli , klebsiella species, morganella morganii , proteus vulgaris , providencia rettgeri ,

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - imipenem (unii: 71otz9ze0a) (imipenem anhydrous - unii:q20im7he75), cilastatin sodium (unii: 5428wxz74m) (cilastatin - unii:141a6amn38) - imipenem and cilastatin for injection, usp (i.v.) for intravenous use is indicated for the treatment of lower respiratory tract infections caused by susceptible strains of staphylococcus aureus (penicillinase-producing isolates), acinetobacter species, enterobacter species, escherichia coli , haemophilus influenzae , haemophilus parainfluenzae , klebsiella species, serratia marcescens . imipenem and cilastatin for injection, usp (i.v.) is indicated for the treatment of urinary tract infections (complicated and uncomplicated) caused by susceptible strains of enterococcus faecalis , staphylococcus aureus (penicillinase-producing isolates), enterobacter species, escherichia coli , klebsiella species, morganella morganii , proteus vulgaris , providencia rettgeri ,

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - imipenem (unii: 71otz9ze0a) (imipenem anhydrous - unii:q20im7he75), cilastatin sodium (unii: 5428wxz74m) (cilastatin - unii:141a6amn38) - imipenem and cilastatin for injection, usp (i.v.) for intravenous use is indicated for the treatment of lower respiratory tract infections caused by susceptible strains of staphylococcus aureus (penicillinase-producing isolates), acinetobacter species, enterobacter species, escherichia coli , haemophilus influenzae , haemophilus parainfluenzae , klebsiella species, serratia marcescens . imipenem and cilastatin for injection, usp (i.v.) is indicated for the treatment of urinary tract infections (complicated and uncomplicated) caused by susceptible strains of enterococcus faecalis , staphylococcus aureus (penicillinase-producing isolates), enterobacter species, escherichia coli , klebsiella species, morganella morganii , proteus vulgaris , providencia rettgeri ,

Canada - English - Health Canada

methapharm inc - imipenem; cilastatin (cilastatin sodium) - powder for solution - 250mg; 250mg - imipenem 250mg; cilastatin (cilastatin sodium) 250mg - carbapenems

Canada - English - Health Canada

methapharm inc - imipenem; cilastatin (cilastatin sodium) - powder for solution - 500mg; 500mg - imipenem 500mg; cilastatin (cilastatin sodium) 500mg - carbapenems

Canada - English - Health Canada

sandoz canada incorporated - imipenem; cilastatin (cilastatin sodium) - powder for solution - 250mg; 250mg - imipenem 250mg; cilastatin (cilastatin sodium) 250mg - carbapenems

Canada - English - Health Canada

sandoz canada incorporated - imipenem; cilastatin (cilastatin sodium) - powder for solution - 500mg; 500mg - imipenem 500mg; cilastatin (cilastatin sodium) 500mg - carbapenems

United States - English - NLM (National Library of Medicine)

wg critical care, llc - imipenem anhydrous (unii: q20im7he75) (imipenem anhydrous - unii:q20im7he75), cilastatin sodium (unii: 5428wxz74m) (cilastatin - unii:141a6amn38) - imipenem and cilastatin for injection, usp for intravenous use is indicated for the treatment of lower respiratory tract infections caused by susceptible strains of staphylococcus aureus (penicillinase-producing isolates), acinetobacter species, enterobacter species, escherichia coli , haemophilus influenzae , haemophilus parainfluenzae , klebsiella species, serratia marcescens. imipenem and cilastatin for injection, usp is indicated for the treatment of urinary tract infections (complicated and uncomplicated) caused by susceptible strains of enterococcus faecalis , staphylococcus aureus (penicillinase-producing isolates), enterobacter species, escherichia coli , klebsiella species, morganella morganii , proteus vulgaris , providencia rettgeri , pseudomonas aeruginosa. imipenem and cilastatin for injection, usp is indicated for the treatment of intra-abdominal infections caused by susceptible strains of enterococcus faecalis , staphylococcus aureus (penicillinase-producing isolates), staphylococcus ep

Canada - English - Health Canada

sun pharma canada inc - imipenem; cilastatin (cilastatin sodium) - powder for solution - 250mg; 250mg - imipenem 250mg; cilastatin (cilastatin sodium) 250mg - carbapenems